Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/NXTCL stock hub

STO/NXTCL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/NXTCLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

137M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/NXTCLSTO/NXTCL

—

Loading chart…

In the news

Latest news · STO/NXTCL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/NXTCL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

SEK

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	24
Employees Change	7%
Employees Change Percent	41.18
Enterprise value	SEK 111M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0009723125
Last refreshed	2026-05-10
Market cap	SEK 137M
Price	SEK 1.23
Price currency	SEK
Rev Per Employee	409,733.88x
Sector	Healthcare
Sic	2836
Symbol	sto/NXTCL
Website	https://www.nextcellpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.31%
EV Earnings	-2.86x
EV/FCF	-2.38x
EV/Sales	11.29x
FCF yield	-33.99%
P/B ratio	2.71x
P/S ratio	13.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	16.83%
Gross Profit	SEK 1.7M
Net Income	SEK -38.8M
Net Income Growth Years	1%
Pretax Margin	-394.49%
Profit Per Employee	SEK -1.6M
ROCE	-70.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.83%
Cagr3y	-39.87%
Cagr5y	-40.51%
EPS Growth Years	2
Revenue Growth	4.08x
Revenue Growth Q	-41.01x
Revenue Growth Years	8x
Revenue Growth3 Y	7.6x
Revenue Growth5 Y	19.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	SEK 63.9M
Cash	SEK 26M
Current Assets	SEK 41.4M
Current Liabilities	SEK 8M
Equity	SEK 50.6M
Interest Coverage	-16,754.3
Liabilities	SEK 13.3M
Long Term Assets	SEK 22.5M
Long Term Liabilities	SEK 5.3M
Net Cash	SEK 26M
Net Cash By Market Cap	SEK 19
Net Debt Equity	SEK -0.51
Tangible Book Value	SEK 50.6M
Tangible Book Value Per Share	SEK 0.45
WACC	7.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.16
Net Working Capital	SEK 7.3M
Quick ratio	3.92
Working Capital	SEK 33.4M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.82%
200-day SMA	1.09
3Y total return	-78.27%
50-day SMA	1.26
50-day SMA vs 200-day SMA	50over200
5Y total return	-92.55%
All Time High	30.4
All Time High Change	-95.95%
All Time High Date	2020-09-29
All Time Low	0.63
All Time Low Change	95.24%
All Time Low Date	2025-11-27
ATR	0.11
Beta	0.65
Beta1y	1.53
Beta2y	-0.1
Ch YTD	68.26
High	1.27
High52	1.78
High52 Date	2026-02-04
High52ch	-31.05%
Low	1.21
Low52	0.63
Low52 Date	2025-11-27
Low52ch	95.24%
Ma50ch	-2.54%
Price vs 200-day SMA	12.84%
RSI	51.08
RSI Monthly	41.48
RSI Weekly	50.58
Sharpe ratio	0.38x
Sortino ratio	0.92
Tr YTD	68.26
Tr1m	-1.6%
Tr1w	17.14%
Tr3m	-22.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -39.5M
Operating margin	-401.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	86,024,295%
Net Borrowing	1,051,845
Shares Insiders	9.03%
Shares Institutions	21.83%
Shares Out	111,392,959
Shares Qo Q	1.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -46.6M
Average Volume	753,515.85x
Bv Per Share	0.45
CAPEX	SEK -4.8M
Ch1m	-1.6
Ch1w	17.14
Ch1y	9.82
Ch3m	-22.54
Ch3y	-78.27
Ch5y	-92.55
Ch6m	50
Change	-0.65%
Change From Open	0.49
Close	1.24
Days Gap	-1.13
Depreciation Amortization	2,493,671
Dollar Volume	391,988.7
Earnings Date	2026-05-28
EBIT	SEK -39.5M
EBITDA	SEK -37M
F Score	1
FCF	SEK -46.6M
FCF EV Yield	-41.97x
FCF Per Share	SEK -0.42
Financing CF	34,985,030
Fiscal Year End	December
Founded	2,014
Investing CF	-5,109,642
Is Primary Listing	1
Last Earnings Date	2026-02-02
Last Report Date	2025-12-31
Ma150	1.08
Ma150ch	14.1%
Ma20	1.23
Ma20ch	0.41%
Net CF	-11,889,237
Next Earnings Date	2026-05-28
Open	1.22
Position In Range	35.29
Ppne	14,267,511
Price Date	2026-05-08
Ptbv Ratio	2.71
Relative Volume	0.43x
Revenue	9,833,613x
Tr6m	50%
Volume	318,690
Z Score	-0.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/NXTCL pay a dividend?

Capital-return profile for this ticker.

Performance

STO/NXTCL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/NXTCL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.8%

Share of float held by funds and institutions

Insider ownership

+9.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

STO/NXTCL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.1

Neutral momentum band

Price vs 200-day MA

+12.8%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/NXTCL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/NXTCL stock rating?

sto/NXTCL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/NXTCL analysis?

The full report lives at /stocks/sto/NXTCL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/NXTCL?

The latest report frames sto/NXTCL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/NXTCL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.